Omeros (OMER) Change in Inventory (2015 - 2026)

Omeros' (OMER) quarterly Change in Inventory came in at $183000.0 in Q1 2026, up 168.8% quarter-over-quarter from -$266000.0 in Q3 2021.

Omeros (OMER) Change in Inventory (2015 - 2026) Analysis & Trends

Omeros has disclosed Change in Inventory across 8 years of filings, most recently posting $183000.0 for Q1 2026.

Change in Inventory for Q1 2026 came in at $183000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$296000.0 (up 53.97% YoY), and the FY2020 annual result was $208000.0, down 80.36% from the prior year.
Change in Inventory came in at $183000.0 for Q1 2026 at Omeros, up from -$266000.0 in the prior quarter.
In the past five years, Change in Inventory ranged from a high of $183000.0 in Q1 2026 to a low of $183000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	51,468.00
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	97.70 Mn
9	Abivax	90.15 Bn	90.15 Bn	-	-
10	Omeros	628.56 Mn	493.24 Mn	9.31 Mn	183,000.00

Download Data